These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 9264256)
21. Hypermutation as a factor contributing to the acquisition of antimicrobial resistance. Blázquez J Clin Infect Dis; 2003 Nov; 37(9):1201-9. PubMed ID: 14557965 [TBL] [Abstract][Full Text] [Related]
22. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes. Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456 [TBL] [Abstract][Full Text] [Related]
23. [Distribution and diversity of conjugative plasmids among some multiple antibiotic resistant E.coli strains isolated from river waters]. Cernat R; Lazăr V; Balotescu C; Cotar A; Coipan E; Cojocaru C Bacteriol Virusol Parazitol Epidemiol; 2002; 47(3-4):147-53. PubMed ID: 15085604 [TBL] [Abstract][Full Text] [Related]
24. Evolution of antibiotic resistance at non-lethal drug concentrations. Andersson DI; Hughes D Drug Resist Updat; 2012 Jun; 15(3):162-72. PubMed ID: 22516308 [TBL] [Abstract][Full Text] [Related]
25. Persistence of antibiotic resistance in bacterial populations. Andersson DI; Hughes D FEMS Microbiol Rev; 2011 Sep; 35(5):901-11. PubMed ID: 21707669 [TBL] [Abstract][Full Text] [Related]
26. Environmental pollution by antibiotics and by antibiotic resistance determinants. Martinez JL Environ Pollut; 2009 Nov; 157(11):2893-902. PubMed ID: 19560847 [TBL] [Abstract][Full Text] [Related]
28. Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase. Weston GS; Blázquez J; Baquero F; Shoichet BK J Med Chem; 1998 Nov; 41(23):4577-86. PubMed ID: 9804697 [TBL] [Abstract][Full Text] [Related]
29. [Guides for rational use of B-lactam antibiotics:resistance mechanism and clinical interpretation]. Arias CA; Panesso D; Zúñiga M Biomedica; 2003 Jun; 23(2):134-40. PubMed ID: 12872552 [TBL] [Abstract][Full Text] [Related]
30. [Mechanisms of bacterial resistance to antibiotics]. Jovanović N; Jovanović J; Stefan-Mikić S; Kulauzov M; Aleksic-Dordević M; Cvjetković D Med Pregl; 2008; 61 Suppl 1():9-14. PubMed ID: 19248637 [TBL] [Abstract][Full Text] [Related]
31. Outsmarting metallo-beta-lactamases by mimicking their natural evolution. Oelschlaeger P J Inorg Biochem; 2008 Dec; 102(12):2043-51. PubMed ID: 18602162 [TBL] [Abstract][Full Text] [Related]
32. In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance. Schentag JJ; Birmingham MC; Paladino JA; Carr JR; Hyatt JM; Forrest A; Zimmer GS; Adelman MH; Cumbo TJ Semin Respir Infect; 1997 Dec; 12(4):278-93. PubMed ID: 9436955 [TBL] [Abstract][Full Text] [Related]
38. Selection of very small differences in bacterial evolution. Baquero F; Negri MC; Morosini MI; Blázquez J Int Microbiol; 1998 Dec; 1(4):295-300. PubMed ID: 10943377 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of genetic determinants involved in beta-lactam- and multiresistance in a surgical ICU. van Loon HJ; Box AT; Verhoef J; Fluit AC Int J Antimicrob Agents; 2004 Aug; 24(2):130-4. PubMed ID: 15288311 [TBL] [Abstract][Full Text] [Related]
40. Resistance of Klebsiella pneumoniae strains producing and not producing ESBL (extended-spectrum beta-lactamase) type enzymes to selected non-beta-lactam antibiotics. Sekowska A; Janicka G; Kłyszejko C; Wojda M; Wróblewski M; Szymankiewicz M Med Sci Monit; 2002 Mar; 8(3):BR100-4. PubMed ID: 11889457 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]